Tonix Pharma (TNXP)
NASDAQ:TNXP

Tonix Pharma Stock Analysis & Ratings

TNXP Stock Chart & Stats

Day’s Range$1.95 - $2.23
52-Week Range$1.91 - $45.44
Previous Close$1.92
Volume8.07M
Average Volume (3M)895.11K
Market Cap$38.70M
P/E Ratio-8.1
Beta1.41
Next EarningsAug 15, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score5
EPS (TTM)-0.24


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

TNXP FAQ

What was Tonix Pharma’s price range in the past 12 months?
Tonix Pharma lowest stock price was $1.91 and its highest was $45.44 in the past 12 months.
    What is Tonix Pharma’s market cap?
    Tonix Pharma’s market cap is $38.70M.
      What is Tonix Pharma’s price target?
      The average price target for Tonix Pharma is $0.60. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $0.60 ,the lowest forecast is $0.60. The average price target represents -70.94% Decrease from the current price of $2.065.
        What do analysts say about Tonix Pharma?
        Tonix Pharma’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Tonix Pharma’s upcoming earnings report date?
          Tonix Pharma’s upcoming earnings report date is Aug 15, 2022 which is in 88 days.
            How were Tonix Pharma’s earnings last quarter?
            Tonix Pharma released its earnings results on May 09, 2022. The company reported -$1.6 earnings per share for the quarter, missing the consensus estimate of -$1.493 by -$0.107.
              Is Tonix Pharma overvalued?
              According to Wall Street analysts Tonix Pharma’s price is currently Overvalued.
                Does Tonix Pharma pay dividends?
                Tonix Pharma does not currently pay dividends.
                What is Tonix Pharma’s EPS estimate?
                Tonix Pharma’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Tonix Pharma have?
                Tonix Pharma has 18,740,000 shares outstanding.
                  What happened to Tonix Pharma’s price movement after its last earnings report?
                  Tonix Pharma reported an EPS of -$1.6 in its last earnings report, missing expectations of -$1.493. Following the earnings report the stock price went down -8.043%.
                    Which hedge fund is a major shareholder of Tonix Pharma?
                    Currently, no hedge funds are holding shares in TNXP

                    ---

                    Tonix Pharma Stock Analysis

                    The Tonix Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Tonix Pharma

                    Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.

                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Pfizer
                    GlaxoSmithKline
                    Horizon Therapeutics
                    Ampio Pharmaceuticals

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis